Sol-Gel's acne candidate meets in Phase II

In February, Sol-Gel Technologies Ltd. (NASDAQ:SLGL) said once-daily low- and high-dose topical cream TWIN (S6G5T) both met the three co-primary endpoints compared with vehicle in a Phase

Read the full 279 word article

User Sign In